Founded in 2024, Shanghai Bailing Biotechnology Co., Ltd. is committed to providing preclinical research and development services for the pharmaceutical and life science industries and focusing on the global import of biological products.

Through years of industry experience in the field of anti-infection, the company has built a comprehensive pre-clinical efficacy and drug formation evaluation and drug discovery and mechanism research platform, and currently has a professional experimental area and P2 cell house. At the same time, close cooperation with relevant key discipline leaders, industry leading enterprises and biomedical parks, to build joint laboratories, professional laboratories, park public service platform as the starting point, to carry out patent transformation verification services, inspection and testing services, preclinical research services, clinical sample testing services, clinical trial information services and other experimental research and development services.